All entries for: Dyne Therapeutics, Inc

November 5, 2025

Dyne Therapeutics, Inc

Neutral Outlook

Waltham, Massachusetts,
501-1,000 employees

On August 16, 2022, the Inflation Reduction Act, or the IRA, was signed into law by President Biden. The new legislation has implications for Medicare Part D, which is a program available to individuals who are entitled to Medicare Part A or enrolled in Medicare Part B to give them the option of paying a monthly premium for outpatient prescription drug coverage.

Disease Area: Neurological
Drug Type: Biologic, Small Molecule
Scroll to Top